Cargando…
204 IGE/IGG4 Ratio as a Possible Surrogate Marker of Clinical Efficacy During Allergen-Specific Immunotherapy with House Dust Mite Vaccines
BACKGROUND: Allergen immunotherapy (AIT) induces IgG4 antibodies with blocking effect, and long-term reduction of IgE. The problem of finding suitable surrogate paraclinical markers during AIT is currently very relevant. The aim was to evaluate the allergen-specific IgE/IgG4 ratio as an immunologica...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
World Allergy Organization Journal
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3512726/ http://dx.doi.org/10.1097/01.WOX.0000411961.02158.51 |